ACELRX PHARMACEUTICALS INC 4
4 · ACELRX PHARMACEUTICALS INC · Filed Apr 11, 2017
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2017-04-10−9,122→ 0 totalExercise: $1.20Exp: 2017-12-05→ Common Stock (9,122 underlying) - Award
Common Stock
2017-04-10$1.20/sh+9,122$10,946→ 73,475 total - Award
Common Stock
2017-04-10+6,879→ 80,354 total
Footnotes (2)
- [F1]Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan.
- [F2]Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months.